e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Bayer Expert Forum at ERS 2014: “Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in Non-CF Bronchiectasis”
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
Source:
International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
Session:
Bayer Expert Forum at ERS 2014: “Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in Non-CF Bronchiectasis”
Session type:
Evening Expert Forum
Number:
4596
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video. International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Jorge Alberto Chancafe Morgan - 21.04.2015 23:15
Excellent presentation!!!
Jorge Alberto Chancafe Morgan - 31.03.2015 02:50
No videos are available!!!!
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Pseudomonas aeruginosa
pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Should pseudomonas aeruginosa be the main target in bronchiectasis?
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Patients with no cystic fibrosis bronchiectasis colonized by
pseudomonas aeruginosa
: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Eosinophilic pneumoniae. Series of clinical cases
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Eradication of Pseudomonas aeruginosa within the baseline dataset of the German Bronchiectasis Registry PROGNOSIS
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Bronchiectasis: Bacteriological profile
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Pseudomonas aeruginosa
colonisation in patients without bronchiectasis
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat?
Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Year: 2020
Primary ciliary dyskinesia: Respiratory tract infections and impact of
pseudomonas aeruginosa
Source: International Congress 2014 – Respiratory physiology and sleep disordered breathing in children
Year: 2014
Pulmonaryhydatid cysts: Evencommon pathology
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly
Source: Eur Respir J 2009; 33: 1448-1453
Year: 2009
LATE-BREAKING ABSTRACT: Sweetening Antibiotic Treatment for Eradication of Bacteria Biofilm
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014
Emerging macrolide-resistant
mycoplasma pneumoniae
in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Roundtable discussion ‘Managing
P. aeruginosa
exacerbations’
Source: International Congress 2014 – Roundtable discussion ‘Managing
P. aeruginosa
exacerbations’
Year: 2014
Mucus clearance devices in bronchiectasis: Indian experience
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
LSC Abstract – Regulation of neutrophilic inflammation in community acquired pneumonia (winner of the LSC 2015 Best Oral Presentation Award)
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
LATE-BREAKING ABSTRACT: Molecular and Phenotypic Characters of Methicillin-resistant
Staphylococcus
aureus
Isolates from Patients with Empyema Thoracis in Central Taiwan
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept